• Home
  • NEW DAY MEDICINE
  • 7 (81) 2025
  • 64 -7 (81) 2025 - Boltaboev A.M., Mamasaliev N.S. - POST - STATUS AND BASIS FOR DEVELOPING FUNDAMENTALLY IMPROVED PROGRAMS FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE DIGESTIVE SYSTEM ASSOCIATED WITH

64 -7 (81) 2025 - Boltaboev A.M., Mamasaliev N.S. - POST - STATUS AND BASIS FOR DEVELOPING FUNDAMENTALLY IMPROVED PROGRAMS FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE DIGESTIVE SYSTEM ASSOCIATED WITH

POST - STATUS AND BASIS FOR DEVELOPING FUNDAMENTALLY IMPROVED PROGRAMS FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE DIGESTIVE SYSTEM ASSOCIATED WITH COVID-19

Boltaboev A.M. - Central Asian Medical University Uzbekistan

Mamasaliev N.S. - Andijan State University

Mamasaliev Z.N. - Andijan State University

Usmonov B.U. - Andijan State University

Boltaboeva D.I. - Fergana Medical Institute of Public Health Fergana region

Resume

The fact that the flow of studies and publications devoted to the Covid-19 pandemic has increased and continues to increase worldwide is evident from the literature review or the reader-researcher may conclude that this is an indication that there are still “mysteries” in the Covid-19 infection. Among these problems, the issue of studying the epidemiology, prevention and radical improvement of treatment methods for Post-Covid-19-associated digestive system diseases is also a cross-cutting and acute medical and social problem. Preventive gastroenterology has begun to develop and find its place in modern medicine, for example, in the case of the Post-Covid-19 population, and the scope of scientific and priority views on reasonable guidelines and recommendations for its improvement has increased. They should be taken into account when determining the topics and directions of scientific research. In our opinion, a very scientific and practical conclusion is drawn: the level of study of modern epidemiological, clinical, pharmacotherapeutic and prophylactic aspects of post-Covid-19 associated digestive system diseases does not meet the requirements. There is a need and a need to analyze and study the existing data from the perspective of preventive medicine. There is a lack of scientific research on the development of radically improved programs for the prevention and treatment of post-Covid-19 associated digestive system diseases and their justification. The expansion and implementation of such meaningful and targeted regional studies with an emphasis on them is of medical, social and economic importance.

Keywords: COVID-19, Post-Covid-19, associated digestive system diseases, epidemiology, prevention, treatment.

First page

332

Last page

337

For citation:Boltaboev A.M., Mamasaliev N.S., Mamasaliev Z.N., Usmonov B.U., Boltaboeva D.I. - POST - STATUS AND BASIS FOR DEVELOPING FUNDAMENTALLY IMPROVED PROGRAMS FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE DIGESTIVE SYSTEM ASSOCIATED WITH COVID-19//New Day in Medicine 7(81)2025 332-337 https://newdayworldmedicine.com/en/new_day_medicine/7-81-2025

List of References

  1. Барановский А.Ю., Беляев А.М., Кондрашина Э.А. По-казатели заболеваемости и смертности от болезней органов пищеварения в СЗФО России и меры, принимаемые по их снижению. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2019;29(1):36-46.
  2. Бутов М.А., Кузнецов П.С., Маслова О.А. Язвенная болезнь это психо-вегето-соматическое или инфекционное заболевание? Эксперим. и клин. гастроэнтерология. 2012;8:82-91.
  3. Ивашкин В.Т., Маев И.В., Царьков П.В., и др. Диагностика и лечение язвенной болезни у взрослых (Клинические рекомендации Российской гастроэнтерологической ассоциации, Российского общества колоректальных хирургов и Российского эндоскопического общества). Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2020;30(1):49-70.
  4. Корочанская Н.В, Дурлештер В.М., Ковалевская О.В., и др. Показатели заболеваемости и смертности от болезней органов пищеварения в Краснодарском крае и качество оказания медицинской помощи гастроэнтерологическим пациентам. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2019;29(4):30-7.
  5. Леонченко С.В., Петюшкин В.Н., Мотин А.П., и др. Клинический случай хирургического лечения пептической язвы гастроэнтероанастомоза. Наука молодых (Eruditio Juvenium). 2021;9(1):101-6.
  6. Лизинфельд И.А., Пшеничная Н.Ю. Паролина Н.Ю., Журавлева Г.Ю. и др. Оценка факторов, влияющих на вероятность госпитализации больных Covid – 19 с сопутствующей патологией, и разработка на их основе прогностической модели // Терапевтический архив. – 2022. – 94 1. – С. 57 – 63.
  7. Ножкина Н.В., Зарипова Т.В., Бессонова Е.Н. Современные ме-дико-социальные аспекты смертности населения от болезней органов пищеварения. Здоровье населения и среда обитания. 2018;12(309):47-52.
  8. Система поддержки принятия врачебных решений. Гастроэнтерология: Клинические протоколы лечения. // Сост. Д.С. Бордин и др. – М. : НИИОММ ДЗМ, 2021.
  9. Стрижаков Л.А., Марченков Р.Е., Шоломова В.И. и др. Covid - 19 у медицинских работников: социально – демографические и клинические особенности при экспертизе связи заболевания с профессией // Профилактическая медицина. – 2024. – Т. - № 27. С. 30 – 36.
  10. Cecconi M, Piovani D, Brunetta E, et al. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. J Clin Med. 2020;9(5):1548. DOI:10.3390/jcm 9051548.
  11. Chen T.H., Cheng H.T., Yeh C.T. Epidemiology changes in peptic ulcer diseases 18 years apari expiored from the genetic aspects of Helicobacter pylori // Transf Res. - 2021:232:115 – 19. Doi. 10.1016/j. trsi. – 2020. – 12. 006.
  12. Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory – Confirmed Coronavirus Disease 2019 – Covid – Net, 14 States, March 1 – 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458 – 64. DOI:10.15585/mmwr.mm6915e35.
  13. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [published correction appears in JAMA. 2021 May 25;325(20):2120]. JAMA. 2020;323(16):1574-81. DOI:10.1001/jama.2020.5394.
  14. Imam Z, Odish F, Gill I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med.2020;288(4):469-76. DOI:10.1111/joim.131191.
  15. Killerby ME, Link-Gelles R, Haight SC, et al. Characteristics Associated with Hospitalization Among Patients with COVID-19 – Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):790-4. DOI:10.15585/mmwr.mm6925e17.
  16. Leow AHR, Lim Y.Y., Liew W.C., Goh K.L. Time trends in upper gastrointestinal diseases and Helocobacter pylori infection in a multiracial. Asian population – A 20 – year experience over three time periods // Aliment Pharmacol Ther. 2016;43(7): 831 – 7. Doi:10.1111/apt. 13550.
  17. Moreno-Pérez Ó, Andrés M, León-Ramirez JM, et al. The COVID-GRAM Tool for Patients Hospitalized With COVID-19 in Europe. JAMA Intern Med. 2021;181(7):1000-1. DOI:10.1001/jamainternmed.2021. 04913.
  18. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. DOI:10.1136/bmj.m1966.
  19. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]. Lancet Respir Med.2020;8(5):475-81. DOI:10.1016/S2213-2600(20)30079-54.
  20. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-62. DOI:10.1016/S0140-6736(20)30566-3.

    file

    download